Galmed Pharmaceuticals Ltd. GLMD
4.63 USD +0.80 (+21.05%)
At closeSep 9, 2026, 4:00 PM EDT
0.57 -4.06 -87.61%
After hours · Sep 9, 4:00 PM ET
3.82 Day range 4.63
2.56 52-week range 23.80
- YTD
- +516.51%
- 1 year
- +158.66%
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 24, 2023 | Maxim Group | Upgrade | Hold | Buy |
| Aug 8, 2022 | Maxim Group | Downgrade | Buy | Hold |
| Aug 8, 2022 | Canaccord Genuity | Downgrade | Buy | Hold |
| May 18, 2022 | Raymond James | Downgrade | Outperform | Market Perform |
| May 3, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| May 3, 2022 | Raymond James | Maintained | — | Outperform |
| May 17, 2021 | Canaccord Genuity | Maintained | — | Buy |
| Mar 19, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Jan 8, 2021 | Raymond James | Maintained | — | Outperform |
| Nov 25, 2020 | Canaccord Genuity | Maintained | — | Buy |
| May 22, 2020 | B. Riley Securities | Downgrade | Buy | Neutral |
| May 15, 2020 | Raymond James | Maintained | — | Outperform |
| Mar 13, 2020 | Stifel | Maintained | — | Buy |
| Mar 13, 2020 | B. Riley Securities | Maintained | — | Buy |
| Feb 4, 2020 | Craig-Hallum | Initiated | — | Buy |
| Jul 22, 2019 | Laidlaw & Co. | Initiated | — | Buy |
| Dec 12, 2018 | B. Riley Securities | Initiated | — | Buy |
| Jul 20, 2018 | Raymond James | Initiated | — | Outperform |
| Jul 13, 2018 | Stifel | Initiated | — | Buy |
| Jul 11, 2018 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 13, 2018 | Maxim Group | Maintained | Buy | Buy |
| Mar 15, 2018 | Maxim Group | Upgrade | Hold | Buy |
| Feb 14, 2018 | Maxim Group | Downgrade | Buy | Hold |
| Nov 15, 2017 | Roth Capital | Initiated | — | Buy |
| Oct 6, 2017 | Seaport Global | Initiated | — | Buy |
| Jun 23, 2015 | HC Wainwright & Co. | Initiated | — | Buy |
| May 6, 2015 | SunTrust Robinson Humphrey | Initiated | — | Buy |
| Apr 15, 2015 | Roth Capital | Initiated | — | Buy |
| May 9, 2014 | MLV & Co. | Maintained | Buy | Buy |